Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in  breast cancer

Yunjie He; Siying Zhou; Fei Deng; Shujie Zhao; Wenquan Chen; Dandan Wang; Xiu Chen; Juncheng Hou; Jian Zhang; Wei Zhang; Li Ding; Jinhai Tang; Zuomin Zhou

doi:doi:10.18632/aging.102490

← Back

Research Paper Volume 11, Issue 23 pp 10883—10901

Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer

Figure 1. Comparison of CD204, CD163, and CD206 mRNA expressions between tumors and normal tissues (A) comparison of CD204 mRNA expression between different subtypes (B) of all cases of breast cancer between stage I-II and III-IV (C), and in each subtype, including luminal A (D), luminal B (E), HER2-positive (F), and basal-like (G) cancers.